| Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind … JF Howard, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, S Jacob, ... The Lancet Neurology 16 (12), 976-986, 2017 | 587 | 2017 |
| Rituximab as treatment for anti-MuSK myasthenia gravis: multicenter blinded prospective review MK Hehir, LD Hobson-Webb, M Benatar, C Barnett, NJ Silvestri, ... Neurology 89 (10), 1069-1077, 2017 | 210 | 2017 |
| Generalized myasthenia gravis: classification, clinical presentation, natural history, and epidemiology MK Hehir, NJ Silvestri Neurologic clinics 36 (2), 253-260, 2018 | 189 | 2018 |
| Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis S Muppidi, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, S Jacob, ... Muscle & nerve 60 (1), 14-24, 2019 | 186 | 2019 |
| Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial GI Wolfe, HJ Kaminski, IB Aban, G Minisman, HC Kuo, A Marx, P Ströbel, ... The Lancet Neurology 18 (3), 259-268, 2019 | 177 | 2019 |
| Treatment-refractory myasthenia gravis NJ Silvestri, GI Wolfe Journal of clinical neuromuscular disease 15 (4), 167-178, 2014 | 147 | 2014 |
| Clinical effects of the self-administered subcutaneous complement inhibitor zilucoplan in patients with moderate to severe generalized myasthenia gravis: results of a phase 2 … JF Howard, RJ Nowak, GI Wolfe, ML Freimer, TH Vu, JL Hinton, ... JAMA neurology 77 (5), 582-592, 2020 | 136 | 2020 |
| International Guillain‐Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in … BC Jacobs, B van den Berg, C Verboon, G Chavada, DR Cornblath, ... Journal of the Peripheral Nervous System 22 (2), 68-76, 2017 | 122 | 2017 |
| International clinimetric evaluation of the MG‐QOL15, resulting in slight revision and subsequent validation of the MG‐QOL15r TM Burns, R Sadjadi, K Utsugisawa, KG Gwathmey, A Joshi, S Jones, ... Muscle & nerve 54 (6), 1015-1022, 2016 | 97 | 2016 |
| Fibrocartilaginous embolism: a comprehensive review of an under-studied cause of spinal cord infarction and proposed diagnostic criteria MA AbdelRazek, A Mowla, S Farooq, N Silvestri, R Sawyer, G Wolfe The Journal of Spinal Cord Medicine 39 (2), 146-154, 2016 | 87 | 2016 |
| Asymptomatic/pauci‐symptomatic creatine kinase elevations (hyperckemia) NJ Silvestri, GI Wolfe Muscle & nerve 47 (6), 805-815, 2013 | 77 | 2013 |
| Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravis KM Clifford, LD Hobson‐Webb, M Benatar, TM Burns, C Barnett, ... Muscle & nerve 59 (4), 404-410, 2019 | 64 | 2019 |
| Spatial mapping of juxtacrine axo-glial interactions identifies novel molecules in peripheral myelination Y Poitelon, S Bogni, V Matafora, G Della-Flora Nunes, E Hurley, ... Nature communications 6 (1), 8303, 2015 | 45 | 2015 |
| Burden of illness in patients with treatment refractory myasthenia gravis NM Engel‐Nitz, A Boscoe, R Wolbeck, J Johnson, NJ Silvestri Muscle & Nerve 58 (1), 99-105, 2018 | 43 | 2018 |
| Macrophages expressing GALC improve peripheral Krabbe disease by a mechanism independent of cross-correction NI Weinstock, D Shin, N Dhimal, X Hong, EE Irons, NJ Silvestri, CB Reed, ... Neuron 107 (1), 65-81. e9, 2020 | 40 | 2020 |
| Clinical significance of serum albumin and implications of FcRn inhibitor treatment in IgG-mediated autoimmune disorders ES Ward, D Gelinas, E Dreesen, J Van Santbergen, JT Andersen, ... Frontiers in immunology 13, 892534, 2022 | 34 | 2022 |
| ‘Minimal symptom expression’in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab J Vissing, S Jacob, KP Fujita, F O’Brien, JF Howard Journal of neurology 267 (7), 1991-2001, 2020 | 34 | 2020 |
| Neuregulin 1 type III improves peripheral nerve myelination in a mouse model of congenital hypomyelinating neuropathy S Belin, F Ornaghi, GG Shackleford, J Wang, C Scapin, C Lopez-Anido, ... Human Molecular Genetics 28 (8), 1260-1273, 2019 | 34 | 2019 |
| Cardiac involvement in the muscular dystrophies NJ Silvestri, H Ismail, P Zimetbaum, EM Raynor Muscle & Nerve 57 (5), 707-715, 2018 | 34 | 2018 |
| Posterior reversible encephalopathy syndrome secondary to blood transfusion K Singh, R Gupta, H Kamal, NJ Silvestri, GI Wolfe Journal of Clinical Neuroscience 22 (3), 592-594, 2015 | 34 | 2015 |
